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 Abstract 
Background: Reduced engagement with habitual activity (HA) is associated with greater 
risk and progression of cognitive decline and falls in older adults and people with dementia. 
Understanding external and intrinsic factors that affect HA may provide novel targets for 
non-pharmacologic interventions.  
Objective: This study primarily aims to identify factors that influence HA in normal ageing 
and cognitive impairment, such as cognitive and motor problems and disease subtype. 
Methods: 108 older adults participated in this study; 36 with cognitive impairment due to 
Alzheimer’s Disease (AD), 30 dementia with Lewy bodies (DLB), 16 Parkinson’s disease 
dementia (PDD) and 26 controls. A tri-axial accelerometer recorded continuous data of 
volume, variability and pattern of HA over seven days. Participants undertook a battery of 
cognitive and neuropsychological assessments. 
Results: One-way analysis of variance analysis controlling for age and gender show that 
people with DLB and PDD engage less with HA compared to controls (p≤.01), but there were 
no significant differences between AD and controls (p≥.01). Multivariate analysis 
demonstrated motor disease and impairments in activities of daily living independently 
explained 10 - 26% of volume, variability and pattern of HA in people with cognitive 
impairment.  
Conclusion: People with cognitive impairment have reduced HA engagement compared to 
controls. Motor disease and impairments in activities of daily living most strongly contribute 
to these findings, and may be important to consider for disease management. Wearable 
technology can provide a personalised picture of an individual’s daily behaviours, and may 
be a useful tool for person-centred care.  
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 Introduction 
Lower levels of every-day (habitual) activities are associated with worse cognitive function 
[3] and wellbeing [4]. Therefore, it may be important to quantify habitual activity (HA) and 
target factors which influence HA when managing cognitive disorders, such as motor 
problems, history of falls and lack of balance confidence.  
Quantification of habitual behaviours using wearable technologies provides a truer picture of 
a person’s overall daily activity (e.g. steps per day, sum of activity counts) compared to self-
report measures, and has been related to global cognitive performance [5], development of 
Alzheimer’s disease (AD) and rate of global cognitive decline [6]. It is unclear if the presence 
of dementia reduces daily activity, or if reduced daily activity contributes to cognitive decline 
[7]. Therefore, a better understanding of the role cognition plays in facilitating daily activity 
in people with cognitive impairment is required.  
However, total daily activity is a broad measure. Considering discrete characteristics relating 
to the volume, pattern and variability of HA allows a more nuanced approach to understand 
these data [8]. Volume refers to amount of activity such as total walking time or number of 
steps taken, while pattern describes length of walking bouts and the relative distribution of 
walking bout lengths, and variability measures the variability of bout lengths. This 
framework of HA allows us to understand the amount and type of activity individuals engage 
with, providing a novel insight into how cognitive impairment may effect a person’s daily 
life. For example, differences in variability and pattern of walking may indicate less 
engagement with different types of HA and shorter bouts may reflect a more constrained 
environment and less time spent outside the home [9]. These novel HA characteristics have 
applications in the identification of frailty in older adults [10], and for the incidence and risk 
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of falls in different neurodegenerative disorders [11,12]. By moving beyond simply 
measuring total daily activity, we can provide a detailed picture of a person’s functional 
abilities and day-to-day activity [8,12,14-16].  
The majority of research into HA in dementia has simply considered volume of activity in 
people with cognitive impairment irrespective of disease subtype [17-21]. As of yet, factors 
which encourage or limit volume, variability and pattern of HA in cognitive impairment have 
not been identified, nor have these novel metrics been described in overarching cognitively 
impaired group or compared between different dementia disease subtypes, such as AD, 
dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). Disease-
specific differences in HA may be an important consideration for disease management and 
care as it may inform which disease subtypes have the greatest need for early interventions.   
Therefore, this study aims move beyond the current research and describe differences in 
volume, pattern and variability of HA between people with cognitive impairment regardless 
of underlying cause and cognitively intact controls, identify  factors that influence HA 
engagement, and consider the impact of dementia disease subtype on HA by comparing 
subgroups of AD, DLB and PDD. We hypothesize that (1). people with cognitive impairment 
of any disease subtype will engage less in HA than controls, and (2). that this will be most 
prominent in people with DLB and PDD as they have concurrent motor problems. We also 
hypothesized that (3.) volume of HA would be explained by lack of balance confidence and 
motor disease burden, while (4.) pattern and variability of HA will be explained by impaired 
cognitive functions.  
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 Materials and Methods 
 Study participants 
125 participants with probable mild cognitive impairment (MCI) and probable dementia due 
to AD, DLB and PD, and controls were recruited. Two independent clinicians reviewed 
participants’ medical notes and assessments in order to verify disease diagnosis. A third 
clinician reviewed disagreements, providing a consensus for diagnosis. Relevant diagnostic 
criteria for AD, DLB and PDD [22-24] and MCI [25,26] were used; MCI due to AD and Lewy 
body disease (LBD) were identified as described in Donaghy, et al. [27], Thomas, et al. [28] 
and King, et al. [29]. Control participants of a similar age were recruited to account for effects 
of ageing on habitual walking behaviours. 
All participants had to be over 60 years old, have capacity to consent and able to walk for two 
minutes, as ascertained by self-report. Participants were excluded if they had drug-induced or 
vascular parkinsonism, any co-existing neurological conditions or movement disorders, severe 
mental illness (major depression, bipolar disorder, schizophrenia), evidence of stroke affecting 
motor function or poor command of the English language. Controls must be cognitively intact 
(Mini Mental State Examination (MMSE) ≥.25), functionally independent, no diagnosis of 
dementia, no diagnosis of Parkinson’s disease and not on any anti- dementia or Parkinson’s 
medication.  
 Clinical Assessment 
Age, gender, height and weight were recorded. All participants reported any falls in the last 12 
months. The National Adult Reading Test (NART)[30], Cumulative Illness Rating Scale – 
Geriatrics (CIRS-G)[31], Movement Disorders Society Unified Parkinson’s Disease Rating 
Scale Part III (UPDRS-III)[32], Clinical Dementia Rating Scale (CDR)[33]; Activities Balance 
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Confidence Scale (ABC)[34], Epworth Sleepiness Scale (ESS)[35], Geriatric Depression Scale 
(GDS)[36], and Bristol Activities of Daily Living Scale (BADLS) were also assessed [37]. 
 Cognitive assessment 
Global cognition was measured using the standardised MMSE (sMMSE) [38] and 
Addenbrookes Cognitive Examination III (ACE-III)[39]. The ACE-III subscales measured 
attention, memory, language, fluency and visuospatial function. Trail Making Task A (TMT-
A) measured information processing speed [40]. The F-A-S Verbal Fluency test measured 
verbal fluency and executive function [41]. The simple reaction time computerised test 
measured attention.  
 Measurement of habitual activity 
Participants were asked to wear a body-worn monitor (Axivity AX3, York, UK; dimensions 
23.0 x 32.5 x 7.6 mm; weight: 11g; accuracy 20 parts per million) on their lower backs 
continuously for seven days. Data from the body-worn monitors was downloaded to a 
computer and segmented by day. Analysis was carried out using a Matlab programme. The 
full process from initial placement of the body-worn sensor through to data extraction and 
output is depicted in Figure 1. A framework of outcomes including volume, pattern and 
variability of walking activity were derived to aid interpretation of data [8] and are described 
below: 
Accelerometer signals were transformed to a horizontal-vertical coordinate system and filtered 
with a 4th order Butterworth filter at 20Hz in order to remove “noise” from the signal. 
For each day, walking bouts were identified by applying selective thresholds on the magnitude 
of vector and the standard deviation of tri-axial acceleration signals (further detailed in [42]). 
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A bout is defined as any continuous period of walking. In order to enhance robustness and 
remain consistent with previous published findings [14,16], a minimum bout length of three 
consecutive steps was applied and there was no resting time threshold – if an individual stopped 
walking, their next three steps would be considered a new bout. 
 The Gaussian continuous wavelet transform of vertical acceleration was applied to smooth 
the data and filter out potential errors [42]. Initial contact (heel strike) and final contact (toe-
off) event of the gait cycle were identified, representing a step. Total steps per bout and bout 
length could be calculated for each bout. Total number of bouts was calculated through 
identification of bouts.  
3.4.1 Volume 
Volume characteristics included total walk time, total steps and total bouts (individual period 
of walking) per day and were calculated by gathering information across all identified bouts. 
These were divided by number of days collected to provide average values per day.  
3.4.2 Pattern 
Characteristics of pattern of walking included mean length of walking bouts, and alpha. 
Alpha is derived by logarithmic transformation of bout density and length and is based on 
shape and power-law distribution [44,45]. Alpha refers to the distribution of bouts, describing 
the ratio of short to long walking bouts which are scaled relative to an individual’s shortest 
walking bout. For example, a high alpha score means total walking time is made up of 
proportionally shorter walking bouts compared to long walking bouts.  
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3.4.3 Variability (S2) 
Variability (S2) refers to variability of bout length between walking bouts and was estimated 
using maximum likelihood technique (previously described Del Din, et al. [9],Mc Ardle, et 
al. [14]).This describes how widespread the data is, providing an estimation of how much an 
individual’s bout length changed across the time period. Low variability may occur when a 
person engages in a low repertoire of activities, while high variability may indicate a person 
is engaging in a wide range of activities – driving a high variability of bout length [12,43]. 
<Insert Figure 1> 
 Data analysis  
Data was assessed for normality by inspection of histograms and boxplots and the Shapiro-
Wilk test. Chi-square tests were used to determine differences between groups for gender and 
faller status (participants with and without falls during the previous year). One-way analysis 
of variance analysis (ANOVAs and Kruskal Wallis tests were used to examine differences 
between groups (p≤.05) for all demographic, cognitive and clinical variables; Fischer’s Least 
significant difference (LSD) post-hocs and Mann Whitney U tests established where 
differences lay between groups in order to assess their comparability. 
First, stepwise analysis of covariance (ANCOVA) assessed differences between controls and 
the overall cognitively impaired group for HA while controlling for age and gender. A more 
stringent statistical threshold of p≤.01 was applied to account for multiple comparisons. 
Effect sizes (partial eta squared: η²) were calculated for key significant differences between 
groups. Effect sizes were interpreted according to guidelines [46]; small (.01-.06), medium 
(.06-.14) and large (>.14).  
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Following this, the relationships between HA and outcomes representing personal, cognitive, 
motor and mood characteristics were explored separately in controls and the cognitively 
impaired group using univariate regression. Only univariate regressions were considered in 
the control group due to the small sample size; however, significant explanatory variables 
were further explored in the cognitively impaired group through multivariate backwards 
stepwise regression. There was no cut off-applied for statistical significance and it was set to 
p≤ .05. 
Finally, stepwise ANCOVA assessed differences in HA between people with AD, DLB and 
PDD and controls (p≤.01) to address the impact of dementia disease subtype on HA 
engagement. Effect sizes (η²) were calculated between groups for significant differences. 
Associations between personal, cognitive and motor outcomes with HA were examined in 
each dementia disease subtype using Spearman Rho correlations, in order to further explore 
disease-specific influences on HA.  
 Results 
 Demographics 
Seventeen patients were excluded from this analysis due to withdrawal from the study (n=2), 
clinical diagnosis other than AD and LBD (n = 11), problems with data upload (n=2), 
monitor lost in the post (n=1) and refusal to wear the sensor (n=1). This left 108 participants; 
82 with cognitive impairment (36 AD, 30 DLB and 16 PDD) and 26 controls. Five 
participants had less than seven days data collected due to hospitalisation (n = 1), discomfort 
(n = 1) and quality checks (n = 3). Participants were still included as data is reported as 
measures per day and all participants had over three days data collected; 3 - 7 days data 
collection is the current standard of free-living gait analysis [47].  
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Participants in the disease groups ranged from MCI to moderate dementia, but groups were 
primarily composed of mild dementia cases (see Table 1 for all clinical and demographic 
information). There were no significant differences for any macro gait characteristics 
between the MCI and dementia groups within each subtype; therefore, it was deemed feasible 
to include both stages of disease in each group (see Supplementary Table 1).  
<Insert Table 1> 
 Differences in habitual activity in cognitive impairment and normal ageing 
Volume: People with cognitive impairment spent significantly less time walking and took 
less steps per day compared to controls (see Table 2).  
Pattern: People with cognitive impairment took significantly shorter walking bouts 
compared to controls. The distribution of their walking bouts demonstrated trends towards a 
greater proportion of short walking bouts compared to long (higher alpha score).  
Variability: People with cognitive impairment demonstrated less variability for bout lengths 
compared to controls.  
<Insert Table 2> 
 Factors that influence habitual activity in normal ageing and cognitive 
impairment 
The significant univariate associations between HA characteristics and possible contributing 
factors (e.g. demographics, motor disease, cognition, balance confidence, impairments in 
activities of daily living) are summarised in Table 3 for the control group, and Table 4 for the 
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cognitively impaired group. All univariate regressions reported in Supplementary Table 2 for 
the control group and in Supplementary Table 3 for the cognitively impaired group.  
<Insert Table 3> 
<Insert Table 4> 
4.3.1 Volume 
In the cognitively impaired group, all volume characteristics were explained by greater motor 
disease severity and greater impairments in activities of daily living (ADLs), explaining 
26.1% of the variance in time spent walking; 20.8% of the variance for steps taken and 17.1% 
of the variance for bouts taken per day (see Table 4). Motor disease severity demonstrated 
moderate-strong negative associations with time spent walking, steps and bouts per day in all 
disease subtypes (see Supplementary Table 4, 5 and 6).  
Volume of HA (walk time per day, steps per day and bouts per day) was not significantly 
explained by any of the considered factors in the control group. 
4.3.2 Pattern  
In the cognitively impaired group, shorter bout lengths were greater motor disease severity, 
accounting for 9% of the variance (see Table 4). Higher alpha scores were explained by 
greater motor disease severity, and greater verbal fluency impairment demonstrated similar 
trends – this model explained 8.9% of the variance. 
Shorter bout length was explained by greater attentional impairment (13.9 % of variance) and 
being female (26.5% of variance; see Table 3), while higher alpha scores were explained by 
being female (19.1% of variance) and older age (16.2% of variance) in controls.  
Habitual activity in cognitive impairment 
12 
 
4.3.3 Variability 
In the cognitively impaired group, greater variability of bout length was explained by 
incidence of a fall within the previous year and greater balance confidence, accounting for 
12.5% of the variance (see Table 4). 
In the control group, less variability of bout length was explained by being female (22.5% of 
variance), greater attentional impairment (17.3% of variance) and slower information 
processing (11.6% of variance; Table 3).  
 The impact of disease subtype on habitual activity in people with cognitive 
impairment 
Volume: People with DLB (p = .003; η² = .161) and PDD walked significantly less (p =.002; 
η²  = .239) ) and took less steps per day (DLB: p = .002, η² =.178; PDD: p = .002, η²=.241) 
compared to controls. There were no significant differences between any groups for number 
of bouts taken per day (p≥.01), or between AD and controls or DLB for any characteristics 
(p≥.01). 
Pattern: The PDD group had a higher alpha score compared to controls (p ≤.001, η²; = .356), 
AD (p≤.001, η²  = .307) and DLB (p = .009, η²  = .156) see Table 2 and Figure 2) and took 
shorter walking bouts (p = .003, η² =.174) compared to the AD group. People with DLB 
(p≤.001, η²  = .287) and PDD (p ≤ .001, η²  = .366) also took shorter walking bouts compared 
to controls. There were no significant differences between AD and controls or DLB (p≥.01). 
Variability: People with PDD (p ≤ .001, η²  .366) and DLB (p≤.001, η²  = .188)  were less 
variable in their walking bout lengths compared to controls. People with PDD were also less 
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variable (p ≤ .001, η² = .206) compared to the AD group. There were no significant 
differences between AD and controls or DLB (p≥.01). 
<Insert Figure 2> 
 Discussion  
The aim of this study was to compare HA between normal ageing and cognitive impairment, 
consider factors that influence HA, and explore the impact of dementia disease subtype on 
HA. Key findings suggest that people with cognitive impairment have lower volume, 
impaired patterns and less variability of HA compared to normal ageing, and this appears 
most prominent in people with DLB and PDD. The factors which influenced HA differed 
between cognitively-intact and cognitively impaired older adults.  
 Factors that influence habitual activity in normal ageing 
This study has provided a novel overview of the differences in HA between cognitively-intact 
older adults and people with cognitive impairment as it goes beyond simply reporting step 
counts and overall activity [48]. Fitting with Hypothesis 1, cognitively-intact older adults 
have a greater volume and variability of HA and take proportionally more longer walking 
bouts compared to people with cognitive impairment. This suggests that people with 
cognitive impairment are less likely to engage in a variety of activities, such as housework 
and social calls, and may be more likely to stay within their own homes. Future research is 
required to provide context to these HA metrics and by doing so, allow wearable technology 
to provide detailed pictures of an individual’s day-to-day function. This may improve our 
understanding of the impact of cognitive impairment on daily living and support the 
development of improved methods for disease management. 
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The influential factors of HA were different between normal ageing and cognitive 
impairment. In normal ageing, gender, age and cognition played a prominent role in 
variability and pattern of HA. The role of gender is consistent with previous literature, 
indicating that the distribution of bout lengths reflect traditional gender roles found in the 
older population [49]. Interestingly, gender did not contribute to HA engagement in people 
with cognitive impairment, which may be due to reduced ability to perform tasks traditionally 
associated with gender roles, and increased dependency and need for care. Future work 
should strive to look at this interaction in larger samples and consider the interaction between 
activity of the individual with cognitive impairment and their caregiver. By doing so, we may 
gain a unique insight into the loss of independence and evolution of caregiving in these 
populations.  
Less variability and impaired pattern of HA was explained by subtle impairments in 
information processing and attention in controls. This may reflect limited abilities to engage 
cognitively with different kinds of activities in the home and community. This partially 
supports Hypothesis 4, however, impairments in cognitive functions did not independently 
contribute to the explanatory models for HA in the cognitive impairment group. Lower 
habitual activity has previously been associated with greater progression and risk of cognitive 
decline in older adults [5,6], suggesting that cognitive function plays an important role in HA 
engagement. However, people with cognitive impairment have a multitude of other factors 
which influence HA, reflecting the multi-factorial nature of MCI and dementia, and these 
may be more prominently associated with lower levels of HA once cognitive impairment is 
established. This study identified these potential factors as motor disease, impairments in 
activities of daily living and dementia disease subtype.  
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 Factors that influence of habitual activity in cognitive impairment 
Lower volume and impaired pattern of HA in people with cognitive impairment were 
strongly explained by greater motor disease severity. This somewhat supports Hypothesis 3 
and previous literature in PD [8]. This relationship has not only been found in the combined 
cognitive impairment group; associations have similarly been found in AD, DLB and PDD 
when considered discretely (see Supplementary Tables 4, 5, 6). This highlights the 
importance of considering motor problems in treatment protocols for MCI and dementia, 
regardless of disease subtype. Cognitive impairment and motor problems are often considered 
separately in clinical practice and may therefore be neglected in individuals without visually 
observable motor symptoms – such as people with AD. It is also important to note that 
dementia disease subtypes with concurrent motor disease, such as DLB and PDD, engage less 
with HA compared to controls and people with AD – confirming Hypothesis 2. As motor 
disease may affect functional independence [50], physical interventions and advice for HA 
maintenance should be implemented soon after symptoms of DLB and PDD are recognised 
[51]. In addition to improving functional independence, this would have added benefit to 
well-being, mood and cognitive function [52-54].  
In addition to motor disease, lower volume of HA was also explained independently by 
greater impairments in ADLs, which can be considered a measure of functional independence 
[55]. Future research should investigate if quantifying HA could act as an objective proxy 
marker for assessing functional independence – reducing patient burden and reliance on self-
reported subjective measures, along with allowing us to explore discrepancies between 
objective measurements and subjective perceptions of daily living. Tailored management of 
ADLs, such as providing unobtrusive aids and supervision of activities [55,56], may promote 
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functional independence and increase or maintain HA – wearable technology could capture 
such outcomes [57].  
 Limitations in our understanding and interpretation of free-living data 
The explanatory models of HA described in this study only explain a small amount of 
variance, and it is important to note there are a broad range of potential influential factors 
which encourage or limit HA engagement. Specific health conditions, apathy and depression, 
fatigue, loss of dependence, caregiver burden and health, lack of access to transportation, bad 
weather and environmental constraints may all act as barriers to engaging in habitual walking 
activities [58]. van Alphen, et al. [58] suggested that there are a range of motivators and 
facilitators for people with cognitive impairment to engage in activity, including dog 
ownership, social activities and routine.  
The large range of HA in this study (see Figure 2) highlights the impact of different limiting 
or encouraging factors on HA. For example, the lowest volume of HA (20 minutes per day) 
was taken by 83 year old woman with PDD. She preferred short walking bouts (alpha: 2.04) 
and reported only feeling safe walking with her husband (ABC: 25/100). Her husband had 
taken over all household task traditionally delegated to her (BADLS: 13/60). The presence of 
motor disease, loss of independence, high levels of caregiving and lack of confidence in 
walking independently may all have influenced low engagement with HA and preference for 
short bouts. In contrast, the highest volume of HA (373 minutes per day) was taken by a 78 
year-old man diagnosed with MCI due to LB. He reported being an active member of a 
walking club that meets regularly. He also had motor disease, but was confident in his 
balance (ABC: 98/100), functionally independent and motivated to engage in social and 
community-based activities.  
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These case studies simply highlight that one size does not fit all. Individuals have a range of 
personal, interpersonal, environmental, cultural and social factors that influence their 
engagement in behavioural activities such as walking. This must be recognised when 
interpreting snapshots of ambulatory activity. Free-living data is complex, personal and 
highly variable. Therefore, monitoring individual trajectories of change within free-living 
behaviours may be more clinically useful than applying thresholds of “at-risk” behaviour 
[59].  
 Considerations and implications for clinical practice 
This research has direct application towards patient-centred care. Firstly, it demonstrates that 
the presence of MCI or dementia is not the only reason for reduced HA. Motor disease and 
reduced engagement with ADLs both additionally may influence lower levels of HA, and 
may be addressed through interventions, such as physical or occupational therapy [60] and 
supervision of tasks rather than direct care [56]. Additionally, future research should consider 
how cognition may be facilitating associations between HA, motor disease and ADLs.  
Secondly, this study has demonstrated feasibility for continuously monitoring HA in different 
dementia disease subtypes with wearable technology. It allows us to describe more than just 
volume of HA, providing a detailed insight into how cognitive impairment affects a person’s 
daily life. There is growing interest in the health industry for the use of wearable technology 
for improving personalised care, and monitoring disease progression and intervention 
efficacy [47,61-65]. In addition to providing personalised pictures of daily activity, it allows 
us to examine under-served areas and move beyond the need for well-controlled 
environments to assess models of “best-practice” [64], reducing observer bias and allowing 
inclusion of populations with high functional impairments. Future research should therefore 
use wearable technology to investigate factors that influence HA in different stages of 
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cognitive impairment, and in different care settings to understand how different 
circumstances contribute to HA engagement.  
 Limitations 
Although this study provided novel evidence for the impact of disease subtype, cognition, 
functional independence and motor disease on HA, along with the feasibility of wearable 
technology to provide a holistic picture of habitual behaviour, it has several limitations. As it 
was a single centre study with a limited catchment area, a small but well-defined sample was 
recruited – multi-centre studies are required to boost participant numbers. The small sample 
size meant we considered a spectrum of cognitive impairment to improve statistical power, 
and did not consider disease-specific factors that influence HA in discrete dementia disease 
subtypes. Larger samples are therefore required to understand impact of dementia severity, 
and to understand disease-specific influencers of HA. Although the benefit of using wearable 
technology is their unobtrusive nature, no questionnaires were administered regarding daily 
activities or caregiver burden – this limited interpretation of results to that known in the 
literature and anecdotal evidence from participants. Finally, it is important to be cautious 
interpreting comparisons between older people with cognitive impairment and similarly-aged 
controls; despite detailed cognitive testing and a consensus approach to the diagnosis and 
categorisation of participants in this study, individuals in “prodromal” stages of MCI and 
dementia are difficult to detect, and may be included in control cohorts in ageing studies.   
 Conclusion 
In conclusion, people with cognitive impairment engage less in HA compared to cognitively-
intact older adults; however, impairments in cognitive functions are not the only influential 
factors of HA in people with MCI and dementia. Motor disease and impairments in activities 
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of daily living most strongly contribute to lack of HA engagement; physical and occupational 
interventions may therefore be useful for facilitating HA and preserving functional 
independence [60]. These interventions may need to implemented earlier in DLB and PDD 
compared to AD, but should still be a primary aim in clinical practice [51]. Wearable 
technology can provide a novel personalised method to measure HA in cognitively impaired 
populations, and may be a useful objective tool for monitoring disease progression and loss 
of independence. Future work is required to understand how disease severity and care settings 
can affect engagement with HA in people with MCI and dementia.  
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